VIATRIS INC. Effective Income Tax Rate Reconciliation Gilti Percent
VIATRIS INC. (VTRS) reported Effective Income Tax Rate Reconciliation Gilti Percent of -1.30% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent · last filed 2026-02-26
- VIATRIS INC. effective income tax rate reconciliation gilti percent for fiscal 2025 was -1.30%.
- VIATRIS INC. effective income tax rate reconciliation gilti percent for fiscal 2024 was -9.90%.
- VIATRIS INC. effective income tax rate reconciliation gilti percent for fiscal 2023 was -69.40%.
- VIATRIS INC. effective income tax rate reconciliation gilti percent for fiscal 2022 was -2.00%, a 105.42% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation Gilti Percent 12 month | Effective Income Tax Rate Reconciliation Gilti Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.30% 10-K · filed 2026-02-26 | |
| 2024-12-31 | -9.90% 10-K · filed 2026-02-26 | |
| 2023-12-31 | -69.40% 10-K · filed 2026-02-26 | 69.40% 10-K · filed 2024-02-28 |
| 2022-12-31 | -2.00% 10-K · filed 2025-02-27 | 2.00% 10-K · filed 2023-02-27 |
| 2021-12-31 | 36.90% 10-K · filed 2024-02-28 | |
| 2020-12-31 | 3.60% 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |